GT
SRRA

Glenmede Trust’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Glenmede Trust’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,889
Closed -$213K – 1408
2022
Q2 		$213K Buy
+3,889
New +$213K ﹤0.01% 1090